Cavid Baba

Cavid Baba

Auto-generated profile, based on publicly available information

Cavid Baba

Graduate School of Health Sciences, Dokuz Eylül University, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
ZAZuhal Abasıyanık
Zuhal Abasıyanık
TKTurhan Kahraman
Turhan Kahraman
ÖEÖzge Ertekin
Özge Ertekin
CBCavid Baba
Cavid Baba
SÖSerkan Özakbaş
Serkan Özakbaş

10 January 2022 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
SOSerkan Ozakbas
Serkan Ozakbas
CBCavid Baba
Cavid Baba
YDYavuz Dogan
Yavuz Dogan
SCSumeyye Cevik
Sumeyye Cevik
SOSinem Ozcelik
Sinem Ozcelik
EKErgi Kaya
Ergi Kaya

5 April 2024 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
MÇMuammer Çelik
Muammer Çelik
CBCavid Baba
Cavid Baba
ÇIÇağlar Irmak
Çağlar Irmak
SÖSerkan Özakbaş
Serkan Özakbaş
VAVildan Avkan-Oğuz
Vildan Avkan-Oğuz
Background: The risk of hepatitis B virus (HBV) reactivation remains unclear in people with multiple sclerosis (MS) receiving ocrelizumab. We aimed to assess HBV seroprevalence and reactivation risk in MS patients on ocrelizumab and to evaluate the effectiveness of antiviral prophylaxis against HBV reactivation. Methods: In this single-center, cross-sectional study, 400 people with MS receiving ocrelizumab were screened for HBV at baseline and antiviral prophylaxis was implemented based on serological results. Patients were monitored for HBV reactivation, and outcomes were analyzed. Results: Among 56 (14%) patients who had serology compatible with occult or resolved HBV infection, 49 (85.7%) received antiviral prophylaxis regularly and had no HBV reactivation during the follow-up. Reactivation of HBV occurred in 2 out of 7 (28.6%) patients who did not receive antiviral prophylaxis and in one patient who did not adhere to the prophylaxis regimen. All patients with reactivation had anti-HBs levels below 100 mIU/mL and the median titer was significantly lower than the patients with no HBV reactivation (p = 0.034). Conclusion: This study highlights a 14% anti-HBc positivity, indicating a potential risk for HBV reactivation in people with MS receiving ocrelizumab. This suggests the importance of vigilant monitoring and the implementation of prophylactic measures. Our recommendation emphasizes antiviral prophylaxis, particularly for patients with low anti-HBs, and a pre-emptive strategy for others.

25 October 2023 in Brain and Behavior
Verified
Journal Article
Open access
TKTurhan Kahraman
Turhan Kahraman
HTHasretgul Temiz
Hasretgul Temiz
ZAZuhal Abasiyanik
Zuhal Abasiyanik
CBCavid Baba
Cavid Baba
SOSerkan Ozakbas
Serkan Ozakbas
Background: No study has investigated the impact of dual‐tasking difficulties as a risk factor for unemployment in people with multiple sclerosis (pwMS). The aim was to examine the influence of dual‐task performance on employment status and work difficulties and to identify the predictors of employment status in pwMS.Methods: Eighty‐four pwMS, including 42 employed and 42 unemployed, participated in the study. Dual‐task difficulties were assessed using the Dual‐task Impact on Daily‐living Activities‐Questionnaire (DIDA‐Q), while dual‐task performance was evaluated through the 30‐second Walk Test and Nine‐Hole Peg Test, incorporating a cognitive task. Walking and cognitive function were also measured.Results: Employed pwMS had better scores in walking, cognitive function, single and dual‐task performance than unemployed pwMS (p < .05). Lower scores in walking (odds ratio [OR] = 1.81, p < .001) and upper extremity‐related (OR = 1.44, p = .019) dual‐task performance and higher scores in the cognitive subscale of the DIDA‐Q questionnaire (OR = 1.20, p = .037) were significantly associated with higher odds of being unemployed. Among employed pwMS, DIDA‐Q subscales showed moderate‐to‐strong correlations with MSWSDQ‐23 scores. The other variables showed weak‐to‐moderate correlations with subscale and total scores of MSWSDQ‐23.Conclusion: Cognitive function, as opposed to motor function, has been found to be a significant predictor of unemployment in pwMS.

28 October 2021 in Neurology and Clinical Neuroscience
Verified
Journal Article
Open access
PDF file
CBCavid Baba
Cavid Baba
PYPinar Yigit
Pinar Yigit
SDSeda Dastan
Seda Dastan
PHPelin Hancer
Pelin Hancer
OSOzge Sagici
Ozge Sagici
ZAZuhal Abasiyanik
Zuhal Abasiyanik
Background: Coronavirus disease of the 2019 pandemic caused much fear among people with chronic diseases and those on immunosuppressant treatment because of spreading knowledge that the infection has a fatal course in these populations. People with Multiple Sclerosis on ocrelizumab treatment share this fear too. We aimed to investigate treatment and lifestyle changes of people with multiple sclerosis on ocrelizumab treatment during the lockdown.Methods: We surveyed 199 of our registered multiple sclerosis patients on ocrelizumab treatment by phone.Results: In this survey, delays in treating 22 (11%) patients were not caused by fear of immunosuppressive drug use but rather by the general fear of contracting a fatal disease, which is the case during traveling and hospital visits. There was a positive correlation between living alone and treatment delay (P = .029), emphasizing the role of family support or just the presence of another person during the pandemic.Conclusion: Vaccines might soon solve the pandemic's issue, which is not the case with multiple sclerosis progression, so we should think twice before discontinuing the treatment.

14 March 2024 in Acta Neurologica Belgica
Verified
Journal Article
Open access
PDF file
ZAZuhal Abasıyanık
Zuhal Abasıyanık
TKTurhan Kahraman
Turhan Kahraman
CBCavid Baba
Cavid Baba
ÖSÖzge Sağıcı
Özge Sağıcı
ÖEÖzge Ertekin
Özge Ertekin
OGon behalf of Multiple Sclerosis Research Group
on behalf of Multiple Sclerosis Research Group
Background: Balance confidence is an essential component of fall risk assessment in persons with multiple sclerosis (pwMS). Aims: The aims of this cross-sectional study were to 1) investigate the ability of the 16-item Activities-specific Balance Confidence scale (ABC-16), 6-item Activities-specific Balance Confidence scale (ABC-6), and each item of the ABC-16 for distinguishing fallers and 2) determine cutoff scores for these scales to discriminate fallers and non-fallers in pwMS. Methods: One hundred and fifty-six participants [fallers/non-fallers: 60 (38.5%)/96 (61.5%), median EDSS: 1.5] were enrolled. Balance confidence was assessed using the ABC-16 and ABC-6. The self-reported number of falls in the past three months was recorded. Descriptive assessments, including walking, balance, and cognition were performed. Logistic regression and receiver operating characteristic analyses were conducted to estimate the sensitivities and specificities of the ABC-16 and ABC-6. Results: Both the ABC-16 (AUC: 0.85) and ABC-6 (AUC: 0.84) had the discriminative ability for falls. Each item of the ABC-16 scale was a significantly related to falls [odds ratio (OR) range: 1.38 to 1.89]. Items 8 and 10 had the highest odds ratio (OR: 1.85; 95%CI: 1.47–2.33, OR: 1.89; 95%CI: 1.49–2.40; respectively). We found cutoff scores of ≤ 70 of 100 (sensitivity: 71.67, specificity: 86.46) and ≤ 65/100 (sensitivity: 76.67, specificity: 79.17) in discrimination between fallers and non-fallers for the ABC-16 and ABC-6, respectively. Conclusion: Both original and short forms of the ABC scale are an efficient tool for discriminating fallers and non-fallers in pwMS. Although all items are related to falls, outdoor walking activities have the strongest associations with falls than other items.